Page last updated: 2024-08-23

daunorubicin and n-oleoylethanolamine

daunorubicin has been researched along with n-oleoylethanolamine in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fernández-Checa, JC; García-Ruiz, C; Llacuna, L; Morales, A; París, R; Villanueva, A	1

Other Studies

1 other study(ies) available for daunorubicin and n-oleoylethanolamine

Article	Year
Pharmacological inhibition or small interfering RNA targeting acid ceramidase sensitizes hepatoma cells to chemotherapy and reduces tumor growth in vivo. Oncogene, 2007, Feb-08, Volume: 26, Issue:6 Topics: Animals; Carcinoma, Hepatocellular; Caspase 3; Cell Proliferation; Daunorubicin; Drug Therapy; Endocannabinoids; Ethanolamines; Galactosylgalactosylglucosylceramidase; Humans; Lysophospholipids; Mice; Microscopy, Electron, Transmission; Mitochondria; Oleic Acids; Protease Inhibitors; RNA, Messenger; RNA, Small Interfering; Sphingosine; Tumor Cells, Cultured; Xenograft Model Antitumor Assays	2007

Article

Year

Pharmacological inhibition or small interfering RNA targeting acid ceramidase sensitizes hepatoma cells to chemotherapy and reduces tumor growth in vivo.

Oncogene, 2007, Feb-08, Volume: 26, Issue:6

Topics: Animals; Carcinoma, Hepatocellular; Caspase 3; Cell Proliferation; Daunorubicin; Drug Therapy; Endocannabinoids; Ethanolamines; Galactosylgalactosylglucosylceramidase; Humans; Lysophospholipids; Mice; Microscopy, Electron, Transmission; Mitochondria; Oleic Acids; Protease Inhibitors; RNA, Messenger; RNA, Small Interfering; Sphingosine; Tumor Cells, Cultured; Xenograft Model Antitumor Assays

2007